Commercialize and partner successfully in Europe and the Middle East
Dr. Stefan Fraenkel, Executive Vice President, Commercial Products, Inceptua Understand how to commercialize via partnering in Europe and other markets…
Read More News and Knowledge
Globally there are approximately 7,000 known rare diseases. About 4,000 – 5,000 of those have no available therapies. Consequently, there are many patients with a rare disease who are waiting…
What’s driving demand for unlicensed medicines in non-launch or non-com-mercialised markets? And what are the challenges for the pharmaceutical manufacturer of not actively engaging in providing access? Irrespective of the manufacturers stance,…
Press Releases
LUXEMBOURG – 10 October 2018 Inceptua Group today announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO). “With Maria joining we are increasing our Medical Leadership, continuing to…
Key appointments strengthen full lifecycle support for pharma LUXEMBOURG – 5 September 2018 – Inceptua Group (previously Multipharma) today announces the strengthening of its Commercial, Strategy, and Supply Chain teams…
